Joshua Cohen

Social justice advocate. Coffee drinker. Obsessive @spotify playlist maker. Husband. Father.

Categories
N/A
Content Types
N/A
More Information
Location|Languages
Publications
N/A

Published Content

45
forbes.com
Article
Trump Administration Throws Down Gauntlet On Drug Prices
January, 16 2019
forbes.com
Article
A QALY Is A QALY Is A QALY, Or Is It?
January, 14 2019
forbes.com
Article
Smartphones Could Boost OTC Drug Utilization And Numbers Of Rx-To-OTC Switches, Too
January, 10 2019
forbes.com
Article
Partial Government Shutdown's Impact On FDA Drug Approvals
January, 10 2019
forbes.com
Article
Unmet Medical Needs Persist Across Many Diseases
December, 26 2018
forbes.com
Article
Looking Into A Crystal Ball: Some Healthcare Predictions For 2019
December, 19 2018
forbes.com
Article
Texas Judge Deals Obamacare A Major Blow
December, 16 2018
forbes.com
Article
Value-Based Pricing And Reimbursement: Still More Promise Than Reality
December, 13 2018
forbes.com
Article
Is It Rational For Employers And Payers To Be Hooked On Prescription Drug Rebates?
December, 10 2018
forbes.com
Article
HHS Making Bundled Payments Mandatory Again
December, 5 2018
forbes.com
Article
Politicians' Narrow Focus On Prescription Drug Spending Is Myopic
December, 3 2018
forbes.com
Article
For Some Patients Financial Toxicity Is Real And Getting Worse
November, 26 2018
forbes.com
Article
4 Million Dollars Or Your Life
November, 19 2018
forbes.com
Article
Medicare Part D Changes: Empowering The Plan, Not Necessarily The Beneficiary
November, 15 2018
forbes.com
Article
Specialty Generics: Barriers To Uptake
November, 12 2018
forbes.com
Article
Risk-Sharing Arrangements May Boost Fortunes Of Certain Prescription Drugs
November, 7 2018
forbes.com
Article
Priority Review Vouchers Revitalizing Neglected Disease Drug Development
November, 5 2018
forbes.com
Article
The New Anti-Flu Drug Xofluza's Value Proposition
November, 1 2018
forbes.com
Article
Trump's Proposed Medicare Drug Pricing Experiment Stokes Fears Of Price Controls
October, 28 2018
forbes.com
Article
Edge In U.S. Cancer Drug Development Spurred By Regulatory And Reimbursement Policies
October, 22 2018
forbes.com
Article
Improving Drug Price Transparency: From Removing Pharmacy Gag Clauses To Reforming The Rebate System
October, 17 2018
forbes.com
Article
Measuring Well-Being: It's More Than GDP
October, 15 2018
forbes.com
Article
Why It's Not So Simple To Standardize The Guides Insurers Use To Pay For Off-Label Cancer Drugs
October, 10 2018
forbes.com
Article
Possible Removal Of Pre-Existing Conditions Protections
October, 8 2018
forbes.com
Article
Cigna And Express Scripts Deal: Virtues Of Vertical Integration
October, 3 2018
forbes.com
Article
Why Payers Sometimes Restrict Access To Single Tablet Regimens For HIV Patients
October, 1 2018
forbes.com
Article
To Include Or Not Include Drug Prices In DTC Ads
September, 24 2018
forbes.com
Article
Will CVS Caremark Make ICER The American NICE?
September, 20 2018
forbes.com
Article
Medicare Advantage Plan Proposed Use Of Step Therapy For Part B Drugs
September, 17 2018
forbes.com
Article
The Curious Case Of Gleevec Pricing
September, 12 2018
forbes.com
Article
Belviq Study Results May Improve The Fortunes Of Weight-Loss Drugs
September, 10 2018
forbes.com
Article
Tanezumab's Phase 3 Results: A Promising Sign For Non-Opioid Pain Treatments
September, 6 2018
forbes.com
Article
Medicaid To Introduce Value-Based Drug Pricing
September, 4 2018
forbes.com
Article
Where Medication Therapy Management/Telehealth Services Deliver Value
August, 24 2018
forbes.com
Article
We're All Suffering From Something -- Is This A Problem?
August, 21 2018
forbes.com
Article
Increasing Numbers of Americans Want Single Payer, But Is That What They Want?
August, 16 2018
forbes.com
Article
Has Amyloid-Based Research Turned The Corner?
August, 13 2018
forbes.com
Article
Better U.S. Patient Access To Cancer Drugs Comes At A Price
August, 9 2018
forbes.com
Article
Changes To Drug Prices: Gestures And Real Policy Shifts
August, 7 2018
forbes.com
Article
Taking A Wider View Of Precision Oncology
August, 2 2018
forbes.com
Article
Right To Try For Some Raises False Hopes For Many
July, 27 2018
forbes.com
Article
Precision Medicine Success Hinges On Diagnostics' Clinical Utility
July, 23 2018
forbes.com
Article
'Diseases Of Despair' Contribute To Declining U.S. Life Expectancy
July, 19 2018
forbes.com
Article
Bold Rx-To-OTC Switches On The Horizon? Naloxone, Perhaps
July, 16 2018
forbes.com
Article
Gradual Progress In Precision Non-Oncology, But Challenges Persist
July, 10 2018
Authorship Stats
1Sites45Projects29,254Words
About
Joshua Cohen is a writer who has produced content for forbes.com
Key Phrases
Drug Prices, Prescription Drug, Cancer Drugs, Trump Administration, Drug Administration, Health Outcomes, Single Payer, List Prices, Medicare Advantage, Step Therapy
© ClearVoice, Inc.